MedTrace Logo

Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms

NCT01522963 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2017-08-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the timeframe (relative to a stress task) that is most effective at attenuating the increase in symptoms of tobacco craving and withdrawal that occur when smokers are presented with stressful situations.

Conditions

  • Tobacco Use Disorder

Interventions

DRUG

Nicotine lozenge

A single dose of nicotine lozenge will be given at various timepoints relative to completion of a somewhat stressful task

Sponsors & Collaborators

Principal Investigators

  • Michael Kotlyar, PharmD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01522963 on ClinicalTrials.gov